HIGHLIGHTS
- who: Olga Krasnova from the Second Affiliated Hospital of Nanchang University, Nanchang, China have published the Article: FARSB serves as a novel hypomethylated and immune cell infiltration related prognostic biomarker in hepatocellular carcinoma, in the Journal: (JOURNAL)
- what: In the study , the possible participation mechanism of FARSB in liver cancer was analyzed using bioinformatics methods based on data from multiple online open databases. The authors first identified elevated mRNA levels of FARSB in hepatocellular carcinoma compared to normal tissues through the Timer online website.
- how: The results showed that FARSB mRNA and protein . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.